CareDx (CDNA) Reaches $5.67 After 7.00% Up Move; Tenet Healthcare New (THC) Shorts Raised By 5.8%

October 16, 2017 - By Kurt Siggers

The stock of CareDx Inc (NASDAQ:CDNA) is a huge mover today! About 122,885 shares traded. CareDx Inc (NASDAQ:CDNA) has declined 74.10% since October 16, 2016 and is downtrending. It has underperformed by 90.80% the S&P500.The move comes after 8 months positive chart setup for the $146.07M company. It was reported on Oct, 16 by Barchart.com. We have $6.07 PT which if reached, will make NASDAQ:CDNA worth $10.22M more.

Tenet Healthcare Corporation New (NYSE:THC) had an increase of 5.8% in short interest. THC’s SI was 33.86M shares in October as released by FINRA. Its up 5.8% from 32.00M shares previously. With 6.00M avg volume, 6 days are for Tenet Healthcare Corporation New (NYSE:THC)’s short sellers to cover THC’s short positions. The SI to Tenet Healthcare Corporation New’s float is 42.19%. About 996,391 shares traded. Tenet Healthcare Corp (NYSE:THC) has declined 36.81% since October 16, 2016 and is downtrending. It has underperformed by 53.51% the S&P500.

CareDx, Inc. is a molecular diagnostics company. The company has market cap of $146.07 million. The Firm is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. It currently has negative earnings. The Company’s commercialized testing solution, the AlloMap heart transplant molecular test , is a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function having a low probability of moderate/severe acute cellular rejection.

Analysts await CareDx Inc (NASDAQ:CDNA) to report earnings on November, 8. They expect $-0.19 earnings per share, down 11.76% or $0.02 from last year’s $-0.17 per share. After $-0.19 actual earnings per share reported by CareDx Inc for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Investors sentiment decreased to 0.73 in 2017 Q2. Its down 0.49, from 1.22 in 2017Q1. It turned negative, as 6 investors sold CareDx Inc shares while 5 reduced holdings. 2 funds opened positions while 6 raised stakes. 6.38 million shares or 18.44% less from 7.82 million shares in 2017Q1 were reported. Thompson Davis reported 6,000 shares or 0.01% of all its holdings. Northern Tru Corporation stated it has 14,089 shares. Vanguard Group Inc has invested 0% in CareDx Inc (NASDAQ:CDNA). Geode Capital Management Lc holds 0% or 43,139 shares in its portfolio. California Pub Employees Retirement Systems reported 175,000 shares. 87,408 are owned by Jpmorgan Chase And. Gagnon Securities Ltd Liability reported 0.64% of its portfolio in CareDx Inc (NASDAQ:CDNA). Highland L P has 0.01% invested in CareDx Inc (NASDAQ:CDNA) for 300,000 shares. Blackrock has 0% invested in CareDx Inc (NASDAQ:CDNA). Tower Research Ltd Liability (Trc) owns 3,911 shares or 0% of their US portfolio. 34,745 were reported by Goldman Sachs Grp. Barclays Public Ltd Co stated it has 41 shares or 0% of all its holdings. Private Wealth Partners Ltd Limited Liability Company holds 10,000 shares. Moreover, Gagnon Advsrs Ltd Company has 0.91% invested in CareDx Inc (NASDAQ:CDNA). Tpg Gp Holdings (Sbs) Advisors Inc accumulated 174,378 shares.

Since May 23, 2017, it had 2 insider buys, and 0 sales for $14,548 activity. 7,439 CareDx Inc (NASDAQ:CDNA) shares with value of $7,439 were bought by GAGNON NEIL.

Among 4 analysts covering CareDx (NASDAQ:CDNA), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. CareDx had 7 analyst reports since September 25, 2015 according to SRatingsIntel. The stock of CareDx Inc (NASDAQ:CDNA) earned “Buy” rating by Craig Hallum on Friday, September 25. The stock of CareDx Inc (NASDAQ:CDNA) earned “Buy” rating by Piper Jaffray on Sunday, September 24. The rating was downgraded by Raymond James to “Market Perform” on Monday, September 28. The firm earned “Outperform” rating on Wednesday, September 27 by Raymond James. Craig Hallum maintained the stock with “Buy” rating in Monday, October 9 report. The rating was maintained by Mizuho with “Buy” on Tuesday, June 14.

Investors sentiment increased to 1.25 in 2017 Q2. Its up 0.11, from 1.14 in 2017Q1. It increased, as 45 investors sold Tenet Healthcare Corp shares while 57 reduced holdings. 41 funds opened positions while 86 raised stakes. 113.66 million shares or 4.07% more from 109.22 million shares in 2017Q1 were reported. Quantbot Tech L P reported 20,839 shares. Stifel Fincl Corp reported 0% stake. Credit Suisse Ag reported 316,996 shares. Texas Permanent School Fund has invested 0.01% of its portfolio in Tenet Healthcare Corp (NYSE:THC). Commonwealth Equity Services Inc has invested 0% of its portfolio in Tenet Healthcare Corp (NYSE:THC). Whitebox Advsrs Llc, Minnesota-based fund reported 302,151 shares. Morgan Stanley reported 0% stake. Pacad Ltd invested 0.1% in Tenet Healthcare Corp (NYSE:THC). Advisory Serv Ltd stated it has 0% in Tenet Healthcare Corp (NYSE:THC). D E Shaw Com accumulated 637,566 shares or 0.02% of the stock. First Eagle Inv Mgmt Ltd Limited Liability Company reported 0.04% in Tenet Healthcare Corp (NYSE:THC). State Common Retirement Fund has invested 0% of its portfolio in Tenet Healthcare Corp (NYSE:THC). Advantus Cap Mngmt accumulated 0.01% or 10,123 shares. Glenview Capital Limited Liability Company has invested 2.24% of its portfolio in Tenet Healthcare Corp (NYSE:THC). 36,713 are held by Voya Invest Mngmt.

Among 21 analysts covering Tenet Healthcare Corporation (NYSE:THC), 8 have Buy rating, 1 Sell and 12 Hold. Therefore 38% are positive. Tenet Healthcare Corporation had 56 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, August 8 by Jefferies. The stock of Tenet Healthcare Corp (NYSE:THC) has “Equal-Weight” rating given on Wednesday, June 7 by Morgan Stanley. Mizuho downgraded Tenet Healthcare Corp (NYSE:THC) on Wednesday, May 4 to “Neutral” rating. The rating was downgraded by Zacks to “Buy” on Friday, August 7. Mizuho downgraded it to “Underperform” rating and $13 target in Tuesday, November 22 report. As per Friday, October 13, the company rating was maintained by Piper Jaffray. The stock has “Outperform” rating by BMO Capital Markets on Friday, September 4. As per Friday, October 2, the company rating was initiated by Citigroup. As per Friday, February 24, the company rating was upgraded by Mizuho. As per Wednesday, April 5, the company rating was maintained by Deutsche Bank.

Tenet Healthcare Corporation is a healthcare services company. The company has market cap of $1.29 billion. The Firm operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. It currently has negative earnings. The Company’s divisions include Hospital Operations and Other, Ambulatory Care and Conifer.